KENNEDY CAPITAL MANAGEMENT LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 266 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 4.64 and the average weighting 0.3%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,139,084
-14.0%
35,699
+3.5%
0.05%
-10.3%
Q2 2023$2,486,296
+130.4%
34,484
+135.1%
0.06%
+81.2%
Q1 2023$1,079,052
+43.6%
14,669
+30.4%
0.03%
+52.4%
Q4 2022$751,300
-22.5%
11,247
-0.1%
0.02%
-27.6%
Q3 2022$970,000
-3.5%
11,260
+0.0%
0.03%
+3.6%
Q2 2022$1,005,000
-16.6%
11,259
+5.1%
0.03%
-3.4%
Q1 2022$1,205,000
-27.8%
10,710
-1.0%
0.03%
-17.1%
Q4 2021$1,670,000
+7.1%
10,815
-3.4%
0.04%0.0%
Q3 2021$1,559,000
+0.2%
11,192
-5.6%
0.04%
+6.1%
Q2 2021$1,556,000
-31.7%
11,862
-20.6%
0.03%
-28.3%
Q1 2021$2,279,000
-79.2%
14,947
-86.4%
0.05%
-81.4%
Q4 2020$10,949,000
+102.2%
110,092
+93.8%
0.25%
+59.4%
Q3 2020$5,414,000
-68.9%
56,797
-63.5%
0.16%
-69.2%
Q2 2020$17,399,000
+46.9%
155,558
-4.5%
0.50%
+15.6%
Q1 2020$11,841,000
+61.9%
162,831
+132.2%
0.44%
+143.0%
Q4 2019$7,312,000
+28.3%
70,114
+22.4%
0.18%
+27.0%
Q3 2019$5,701,000
+207.7%
57,277
+252.9%
0.14%
+220.5%
Q2 2019$1,853,000
-84.1%
16,232
-82.5%
0.04%
-68.1%
Q1 2019$11,636,000
+650.7%
92,556
+710.3%
0.14%
+263.2%
Q4 2018$1,550,000
-88.1%
11,422
-75.9%
0.04%
-84.3%
Q3 2018$13,032,000
+35.1%
47,478
+2.0%
0.24%
+34.4%
Q2 2018$9,646,000
+28.3%
46,562
+2.2%
0.18%
+23.3%
Q1 2018$7,521,000
+18.5%
45,540
-1.7%
0.15%
+28.1%
Q4 2017$6,346,000
+0.1%
46,345
-0.5%
0.11%0.0%
Q3 2017$6,339,00046,5580.11%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders